The National Academy of Sciences and the National Academy of Medicine launched this initiative in 2015 to inform decision-making related to recent advances in human gene-editing research. [Learn about related Academies’ studies and reports on genetic research]
Second International Summit on Human Genome Editing To Be Held in Hong Kong
The Second International Summit on Human Genome Editing will take place Nov. 27-29, 2018, in Hong Kong. The three-day summit will be co-hosted by the Academy of Sciences of Hong Kong, the Royal Society of London, the U.S. National Academy of Sciences, and the U.S. National Academy of Medicine. The summit will be held in the Lee Shau Kee Lecture Centre at the University of Hong Kong and be webcast live.
The science of human genome editing has advanced rapidly since the first international summit was held in 2015 in Washington, D.C. An explosion of new research is employing CRISPR/Cas9 and other powerful, precise editing tools, and clinical trials are planned for applications to treat diseases. However, many questions remain unanswered concerning the science, application, ethics, and governance of human genome editing. Of particular concern is the possibility of genome editing that might lead to heritable alterations, and applications for purposes other than to treat diseases or disabilities.
The Second International Summit on Human Genome Editing will continue to advance the global discussion on these issues by bringing together a broad range of stakeholders — including researchers, ethicists, policy makers, patient groups, and representatives from science and medical academies and organizations worldwide. The four Academies are appointing an international, multidisciplinary program committee to plan the summit and develop the agenda.